Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

(2018) F Cardoso et al.   ANNALS OF ONCOLOGY

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

(2018) Pavlos Msaouel et al.   CURRENT CANCER DRUG TARGETS

Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis

(2018) Yuhyun Chung et al.   Cell Death & Disease

Oncolytic viruses: emerging options for the treatment of breast cancer

(2017) Yogesh R. Suryawanshi et al.   MEDICAL ONCOLOGY

Autophagy in Measles Virus Infection

(2017) Aurore Rozières et al.   Viruses-Basel

Review: Oncolytic virotherapy, updates and future directions

(2017) Christos Fountzilas et al.   Oncotarget

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

(2016) M. M-Rabet et al.   ANNALS OF ONCOLOGY

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

(2016) P. M. Challita-Eid et al.   CANCER RESEARCH

The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein

(2016) Liang-Tzung Lin et al.   Viruses-Basel

Measles to the Rescue: A Review of Oncolytic Measles Virus

(2016) Sarah Aref et al.   Viruses-Basel

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer

(2015) Satoshi Nishiwada et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

(2015) Chen-Jei Tai et al.   Jove-Journal of Visualized Experiments

Autophagy inhibition switches low-dose camptothecin-induced premature senescence to apoptosis in human colorectal cancer cells

(2014) Jian-wei Zhang et al.   BIOCHEMICAL PHARMACOLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene

(2014) Can Yurttas et al.   Human Gene Therapy Clinical Development

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer

(2014) Andrew Nguyen et al.   Frontiers in Oncology

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

(2013) Liang-Tzung Lin et al.   BMC MICROBIOLOGY

An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis

(2013) J Lampe et al.   GENE THERAPY

Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase

(2013) A.D. Hartkopf et al.   GYNECOLOGIC ONCOLOGY

A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma

(2013) Sebastian Lange et al.   HUMAN GENE THERAPY

Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses

(2013) Timo Weiland et al.   INTERNATIONAL JOURNAL OF CANCER

A role for PVRL4-driven cell–cell interactions in tumorigenesis

(2013) Natalya N Pavlova et al.   eLife

Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy

(2012) Sonia Tusell Wennier et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

(2012) K-W Peng et al.   GENE THERAPY

Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus

(2012) Johanna K. Kaufmann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β–glucuronidase in tumors

(2011) P-T Huang et al.   CANCER GENE THERAPY

Armed and targeted measles virus for chemovirotherapy of pancreatic cancer

(2011) S Bossow et al.   CANCER GENE THERAPY

Mutation in PVRL4 gene encoding nectin-4 underlies ectodermal-dysplasia-syndactyly syndrome (EDSS1)

(2011) Musharraf Jelani et al.   JOURNAL OF HUMAN GENETICS

Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread

(2011) L.-T. Lin et al.   JOURNAL OF VIROLOGY

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

(2011) Michael D. Mühlebach et al.   NATURE

Expression of Measles Virus Nucleoprotein Induces Apoptosis and Modulates Diverse Functional Proteins in Cultured Mammalian Cells

(2011) Ashima Bhaskar et al.   PLoS One

Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus

(2011) Ryan S. Noyce et al.   PLoS Pathogens

Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum

(2010) Melissa S. DeRycke et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics

(2010) G Ungerechts et al.   GENE THERAPY

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer

(2010) C K Ingemarsdotter et al.   ONCOGENE

Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer

(2009) A. Takano et al.   CANCER RESEARCH

Intelligent Design: Combination Therapy With Oncolytic Viruses

(2009) Kathryn Ottolino-Perry et al.   MOLECULAR THERAPY

Virotherapy as An Approach Against Cancer Stem Cells

(2008) Camilla Ribacka et al.   CURRENT GENE THERAPY